CKB is a dynamic digital resource for interpreting complex cancer genomic profiles in the context of protein impact, therapies, and clinical trials. CKB CORE is the public access version we have been providing to the community since 2016. CKB CORE contains all the content associated with 50 genes that are commonly found on cancer hotspot panels. New and updated content is pushed out daily and viewable genes are available on a quarterly rotating schedule.
News
Oct 14, 2024
-
Attention CKB CORE users, it's time for the update to the CORE gene list! This quarter we are highlighting the tumor suppressor genes. If you have any questions or comments, please don't hesitate to reach out to us at ckbsupport@genomenon.com. Thank you for the continued support of CKB!
May 8, 2024
-
Genomenon acquires CKB! CKB is now part of Genomenon, unlocking unprecedented insights into the genome. Read the full announcement here.
CKB Explore the Mastermind Genomic Intelligence Platform
Access article information on over 26 million variants, as well as curated germline variant content,
and discover valuable gene and variant summary information to streamline your analysis and deepen your insights.
